To understand how Artemis can help you tackle your GLP-1 strategy, reach out to [email protected]
If you have a family or personal history of medullary thyroid cancer or a rare condition called multiple endocrine neoplasia syndrome type 2 (MEN2), you should not take Ozempic
The effect of GLP-1 receptor agonists on metabolic profile in patients with obesity and type 2 diabetes
Pay attention to any updates regarding policy changes effective January 1, 2025, which may influence your access to GLP-1 drugs
There are so many meals to choose from
"Tracking performance helps one identify patient safety hazards, understand baseline performance, and assess if changes in performance are sustained." Ulfat Shaikh, MD, MPH, MS, Agency for Healthcare Research and Quality Schedule Regular Doctor Visits Your healthcare provider is a key partner in assessing whether your maintenance dose is working as intended